Sonova (OTCMKTS:SONVY – Get Free Report) and Baird Medical Investment (NASDAQ:BDMD – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.
Insider and Institutional Ownership
0.0% of Sonova shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 0.0% of Sonova shares are held by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Sonova and Baird Medical Investment’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sonova | N/A | N/A | N/A |
| Baird Medical Investment | N/A | N/A | N/A |
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sonova | $4.50 billion | 3.14 | $536.96 million | N/A | N/A |
| Baird Medical Investment | $22.54 million | 1.85 | N/A | N/A | N/A |
Sonova has higher revenue and earnings than Baird Medical Investment.
Analyst Recommendations
This is a summary of recent ratings and price targets for Sonova and Baird Medical Investment, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sonova | 1 | 3 | 1 | 2 | 2.57 |
| Baird Medical Investment | 1 | 0 | 0 | 0 | 1.00 |
Risk & Volatility
Sonova has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -1.22, indicating that its share price is 222% less volatile than the S&P 500.
Summary
Sonova beats Baird Medical Investment on 6 of the 8 factors compared between the two stocks.
About Sonova
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
About Baird Medical Investment
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.
